Disposable cleanroom launched by UK's RLS
Related Life Sciences of the UK has launched an inexpensive way of converting existing rooms into temporary isolation suites within just 10 minutes.
Archives for September 19, 2005
Scientists' terminator' virus destroys tumour growth
US scientists have claimed to have developed the next generation of effective viral-based therapies for cancer in which 'terminator' viruses are deployed to destroy primary tumours.
MerLion and CRT in UK-Asia cancer deal.
MerLion Pharmaceuticals has entered into a large-scale screening programme with Cancer Research Technology (CRT) to identify new anti-cancer drug candidates derived from natural product chemistry.
Nanostructures build next-gen lab equipment
A previously unknown zinc oxide nanostructure is set to provide a new building block for creating laboratory equipment that rely on electromechanical coupling. The material's cost and flexibility makes it suitable for biomedical applications, which...
Orally-absorbed paclitaxel clears Phase I trial
French drug delivery company Novagali Pharma has completed early-stage clinical testing of an oral formulation of paclitaxel, a widely used cancer drug usually delivered by intravenous infusion.
Biotrace expands in pharma with MicroSafe acquisition
Biotrace of the UK has acquired MicroSafe Group, an Italian supplier of microbiological testing products for the pharmaceutical, food and defence sectors, for £2.5 million.
Inspection specialist Key opens dedicated pharma unit
Key Technology has set up a dedicated pharmaceutical business unit, Symetix, to lend some focus to its efforts to sell automated inspection and specialised conveying systems to the drug industry.
Zentiva buys Sicomed in latest generics M&A
The consolidation in the generic pharmaceutical industry continues apace, with companies in the easterly reaches of Europe now getting in on the act. Czech Republic-headquartered Zentiva has signed an agreement to acquire 51 per cent of S C Sicomed,...